351. [Clinical studies on TUR-P using clinical path: report of 50 cases and review of literature]
- Author
-
Shingo Sugaya, Tatsuya Shimomura, Takehito Naruoka, Hiroshi Omono, Hiroki Yamada, Shigetaka Maeda, Koji Asano, Yukihiko Oishi, Yutaka Shiono, Hiroshi Sasaki, and Jun Miki
- Subjects
Aged, 80 and over ,Male ,medicine.medical_specialty ,Medical treatment ,National Health Programs ,business.industry ,Critical pathways ,Urology ,General surgery ,Treatment outcome ,Prostatic Hyperplasia ,Transurethral Resection of Prostate ,Length of Stay ,Middle Aged ,University hospital ,Medical insurance ,Transurethral prostatectomy ,Treatment Outcome ,Japan ,Critical Pathways ,Medicine ,Humans ,business ,Hospital stay ,Aged - Abstract
PURPOSE This study was undertaken to clarify the usefulness and problems involved in the clinical path of transurethral prostatectomy (TUR-P) in hospital. PATIENTS AND METHODS The subjects consisted of 50 patients, for whom the Department of Urology, Jikei Medical University Hospital introduced its own clinical path and performed TUR-P during a period of 9 months from July 1999 to March 2000. The mean length of hospital stay, rate of postoperative complications, and the medical insurance claims made by these patients were clarified and compared with those of 73 patients before introduction of the clinical path. RESULTS With the introduction of the clinical path, the length of hospital stay decreased by an average of 3.4 days and the total medical insurance claims decreased by an average of 18.5%. The rate of postoperative complications before and after introduction was almost equal. CONCLUSION Our clinical path for TUR-P was well accepted by both patients and comedicals. However, the present medical treatment system in Japan is not as yet prepared to promote the introduction of this clinical path, and it will take some time before this clinical path is introduced on a full scale.
- Published
- 2003